Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Metropolis Healthcare...

    Metropolis Healthcare plans to add 800 centres, 10 labs by FY19 end

    Written by Ruby Khatun Khatun Published On 2018-03-26T11:00:01+05:30  |  Updated On 26 March 2018 11:00 AM IST
    Metropolis Healthcare plans to add 800 centres, 10 labs by FY19 end

    New Delhi: Diagnostic chain Metropolis Healthcare is planning to add 800 collection centers and around 10 laboratories by the end of next fiscal, a top company official has said.


    The company currently has 150 labs with 1,800 collection centers and processes over 4,500 varieties of tests.


    "We are planning to add 800 centers and around 10 labs by the end of next financial year as part of our expansion plans," Metropolis Healthcare Promoter and Managing Director Ameera Shah told PTI.


    As part of the company's growth strategy, it would expand its geographical presence in North and Eastern parts of the country while growing depth in South and West, she added.


    "The business in North and East parts of India is growing quite fast. Punjab is a big market for us. In Delhi also, we have done very well," Shah said.


    During the last year, the company has set up labs in Ludhiana, Khanna, Ghaziabad, Dhanbad. We have also added labs in Kolkata, Patna, and Delhi, she added.


    About the southern and western regions of the country, Shah said: "We are very clear leaders in West and South. Here we have to build much more depth. We are going deeper and nearer to the patients."


    The company is currently present in seven countries - India, Ghana, Kenya, Zambia, Uganda, Mauritius and Sri Lanka.


    When asked if the company was planning to enter into more countries, Shah said: "In Africa, we will keep growing, we are looking to enter one or more countries there."


    The interest is now on building dominance and market leadership in the places that the company is present, she added.


    On being asked about how the company plans to raise funds for the expansion, Shah said: "Expansion will be done through internal accruals. We are also planning to invest around Rs 60 crore over the next two to three years in technology."


    The company had entered a public-private partnership three months ago with National Aids Control Organisation (NACO) for a three-year project to organize a collection of blood and testing for HIV at 560 locations across India, Shah said.


    "We bring the samples on a weekly basis and bring them to our lab in Mumbai and do the testing and give the report back to the concerned," she added.


    Metropolis Healthcare conducts more than 30 million tests a year catering to over 20,000 laboratories, hospitals, nursing homes and 2 lakh consultants.


    It offers comprehensive testing in the areas of genetics biochemistry, molecular oncology, anatomic pathology, microbiology, haematology, immunochemistry, among others.

    Ameera Shahcollection centersHIVlaboratoriesMetropolisMetropolis HealthcareNACONational Aids Control Organisationplanspublic private partnership
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok